RTW Investments holds 9.7% · +1.4pp on the report before
Filed 08/14
Stocks
All insider trades in CG Oncology
All planned sales of CG Oncology
CG Oncology CGON
Health care sectorNasdaq
What to see in CG Oncology now
Company
- Exchange
- Nasdaq
- Sector
- Health care
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Dallas, Texas
- Fiscal year end
- 12/31
- Next earnings
- 11/04, estimated
- $5.2M of planned sales filed in 30 days · 0.1% of the units outstandingFiled 09/21
Insider trades
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Brian Guan-Chyun LiuDirector | Open-market buy10b5-1 plan | 06/25 | 06/29 | 371,085 sh | $66.87 | $24,814,453.95 | +24.5% |
Leonard E. PostDirector | Open-market sale10b5-1 plan | 06/24 | 06/25 | 5,000 sh | $70.00 | $350,000 | −100.0% |
Leonard E. PostDirector | Open-market sale10b5-1 plan | 06/22 | 06/23 | 5,000 sh | $65.00 | $325,000 | −100.0% |
James MulayDirector | Open-market sale10b5-1 plan | 06/15 | 06/16 | 654 sh | $60.12 | $39,318.48 | −100.0% |
James MulayDirector | Open-market sale10b5-1 plan | 06/15 | 06/16 | 1,310 sh | $60.12 | $78,757.2 | −100.0% |
Planned sales
Ambaw BelleteOfficer | CG OncologyCGON | 30,787 sh | $2,340,024.43 | 09/21 | Filed 09/21 |
Ambaw BelleteOfficer | CG OncologyCGON | 6,532 sh | $499,698 | 09/17 | Filed 09/17 |
Ambaw BelleteOfficer | CG OncologyCGON | 826 sh | $61,950 | 09/11 | Filed 09/11 |
Ambaw BelleteOfficer | CG OncologyCGON | 29,630 sh | $2,299,448 | 09/02 | Filed 09/02 |
Ambaw BelleteOfficer | CG OncologyCGON | 50,000 sh | $3,775,250 | 08/31 | Filed 08/31 |
Ambaw BelleteOfficer | CG OncologyCGON | 5,789 sh | $459,560.92 | 08/27 | Filed 08/27 |
Ambaw BelleteOfficer | CG OncologyCGON | 10,551 sh | $839,338.38 | 08/25 | Filed 08/25 |
Ambaw BelleteOfficer | CG OncologyCGON | 5,762 sh | $458,185.02 | 08/24 | Filed 08/24 |
Ambaw BelleteOfficer | CG OncologyCGON | 100,000 sh | $7,954,105 | 08/19 | Filed 08/19 |
Ambaw BelleteOfficer | CG OncologyCGON | 52,438 sh | $4,034,894.35 | 08/17 | Filed 08/17 |